Novel therapeutics in thoracic cancers including early phase trials
Targeted therapy trials, genomics in thoracic cancers
Immunotherapy trials in thoracic cancers
Novel diagnostics including practical applications of liquid biopsy
Outcomes research
Related Links
Associated Program(s)
For a list of Dr. Leighl's publications, please visit PubMed or Scopus.
Clinician Investigator, Princess Margaret Cancer Centre
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Professor, Department of Medicine, University of Toronto Professor (status), Institute of Health Policy, Management and Evaluation, University of Toronto Past President and Honorary Lifetime Member, Lung Cancer Canada Past Chair, Committee on Economic Analysis, Canadian Clinical Trials Group